Abstract
This chapter reviews the history and modern applications of isolated preparations of the three main CNS barrier layers and cell culture preparations derived from them. In vitro models give valuable mechanistic information but also provide useful assay systems for drug discovery and delivery programmes. However, it is important to take into account practical issues including species differences and the degree to which the differentiated state of the in vivo barrier is retained. The range of models available is reviewed, with a critical evaluation of their strengths and weaknesses, and guidance in selecting and optimizing a suitable model for particular applications. New understanding of the unstirred water layers and paracellular leak pathway in in vitro preparations gives greater insights into the “intrinsic permeability” of the membrane, and a variety of techniques permit characterization of the transport systems and enzymes contributing to barrier function. Increasingly, aspects of CNS pathology are being modelled in cell culture, aiding the optimization of drug delivery regimes in pathological conditions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abbott NJ (2004) Prediction of blood-brain barrier permeation in drug discovery from in vivo, in vitro and in silico models. Drug Discov Today Technol 1:407–416
Abbott NJ (2013) Blood-brain barrier structure and function and the challenges for CNS drug delivery. J Inherit Metab Dis 36:437–449
Abbott NJ, Dolman DE, Drndarski S, Fredriksson SM (2012) An improved in vitro blood-brain barrier model: rat brain endothelial cells co-cultured with astrocytes. Methods Mol Biol 814:415–430
Angelow S, Zeni P, Galla HJ (2004) Usefulness and limitation of primary cultured porcine choroid plexus epithelial cells as an in vitro model to study drug transport at the blood-CSF barrier. Adv Drug Deliv Rev 56:1859–1873
Audus KL, Borchardt RT (1986) Characterisation of an in vitro blood-brain barrier model system for studying drug transport and metabolism. Pharm Res 3:81–87
Audus KL, Rose JM, Wang W, Borchardt RT (1998) Brain microvessel endothelial cell culture systems. In: Pardridge WM (ed) Introduction to the blood-brain barrier: methodology, biology and pathology. Cambridge University Press, Cambridge
Avdeef A (2011) How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability? Eur J Pharm Sci 43:109–124
Avdeef A (2012) Absorption and drug development: solubility, permeability and charge state, 2nd edn. Wiley, Hoboken, NJ
Baehr C, Reichel V, Fricker G (2006) Choroid plexus epithelial monolayers - a cell culture model from porcine brain. Cerebrospinal Fluid Res 3:13
Ball K, Bouzom F, Scherrmann JM, Walther B, Declèves X (2012) Development of a physiologically based pharmacokinetic model for the rat central nervous system and determination of an in vitro-in vivo scaling methodology for the blood-brain barrier permeability of two transporter substrates, morphine and oxycodone. J Pharm Sci 101:4277–4292
Ball K, Bouzom F, Scherrmann JM, Walther B, Declèves X (2013) Physiologically based pharmacokinetic modelling of drug penetration across the blood-brain barrier – towards a mechanistic IVIVE-based approach. AAPS J 15:913–932
Ballermann BJ, Dardik A, Eng E, Liu A (1998) Shear stress and the endothelium. Kidney Int Suppl 67:S100–S108
Benson K, Cramer S, Galla HJ (2013) Impedance-based cell monitoring: barrier properties and beyond. Fluids Barriers CNS 10(1):5. doi:10.1186/2045-8118-10-5
Booth R, Kim H (2012) Characterization of a microfluidic in vitro model of the blood-brain barrier (μBBB). Lab Chip 12:1784–1792
Bouldin TW, Krigman MR (1975) Differential permeability of cerebral capillary and choroid plexus to lanthanum ion. Brain Res 99:444–448
Bowman PD, Betz AL, Ar D, Wolinsky JS, Penney JB, Shivers RR, Goldstein GW (1981) Primary culture of capillary endothelium from rat brain. In Vitro 17:353–362
Bowman PD, Ennis SR, Rarey KE, Betz AL, Goldstein GW (1983) Brain microvessel endothelial cells in culture: a model for study of blood-brain barrier permeability. Ann Neurol 14:396–402
Brendel K, Meezan E, Carlson EC (1974) Isolated brain microvessels: a purified, metabolically active preparation from bovine cerebral cortex. Science 185:953–955
Burek M, Salvador E, Förster CY (2012) Generation of an immortalized murine brainmicrovascular endothelial cell line as an in vitro blood brain barrier model. J Vis Exp 29(66):e4022. doi:10.3791/4022
Campos CR, Schröter C, Wang X, Miller DS (2012) ABC transporter function and regulation at the blood-spinal cord barrier. J Cereb Blood Flow Metab 32:1559–1566
Candela P, Gosselet F, Saint-Pol J, Sevin E, Boucau MC, Boulanger E, Cecchelli R, Fenart L (2010) Apical-to-basolateral transport of amyloid-β peptides through blood-brain barrier cells is mediated by the receptor for advanced glycation end-products and is restricted by P-glycoprotein. J Alzheimers Dis 22:849–859
Cecchelli R, Dehouck B, Descamps L, Fenart L, Buée-Scherrer V, Duhem C, Lundquist S, Rentfel M, Torpier G, Dehouck MP (1999) In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 36:165–178
Cohen-Kashi Malina K, Cooper I, Teichberg VI (2009) Closing the gap between the in-vivo and in-vitro blood-brain barrier tightness. Brain Res 1284:12–21
Cohen-Kashi-Malina K, Cooper I, Teichberg VI (2012) Mechanisms of glutamate efflux at the blood-brain barrier: involvement of glial cells. J Cereb Blood Flow Metab 32:177–189
Coisne C, Dehouck L, Faveeuw C, Delplace Y, Miller F, Landry C, Morissette C, Fenart L, Cecchelli R, Tremblay P, Dehouck B (2005) Mouse syngenic in vitro blood-brain barrier model: a new tool to examine inflammatory events in cerebral endothelium. Lab Invest 85:734–746
Cucullo L, Couraud PO, Weksler B, Romero IA, Hossain M, Rapp E, Janigro D (2008) Immortalized human brain endothelial cells and flow-based vascular modeling: a marriage of convenience for rational neurovascular studies. J Cereb Blood Flow Metab 28:312–328
Cucullo L, Hossain M, Puvenna V, Marchi N, Janigro D (2011) The role of shear stress in blood-brain barrier endothelial physiology. BMC Neurosci 12:40
Cucullo L, McAllister MS, Kight K, Krizanac-Bengez L, Marroni M, Mayberg MR, Stanness KA, Janigro D (2002) A new dynamic in vitro model for the multidimensional study of astrocyte-endothelial cell interactions at the blood-brain barrier. Brain Res 951:243–254
Culot M, Lundquist S, Vanuxeem D, Nion S, Landry C, Delplace Y, Dehouck MP, Berezowski V, Fenart L, Cecchelli R (2008) An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening. Toxicol In Vitro 22:799–811
Daneman R, Zhou L, Agalliu D, Cahoy JD, Kaushal A, Barres BA (2010a) The mouse blood-brain barrier transcriptome: a new resource for understanding the development and function of brain endothelial cells. PLoS One 5(10):e13741. doi:10.1371/journal.pone.0013741
Daneman R, Zhou L, Kebede AA, Barres BA (2010b) Pericytes are required for blood-brain barrier integrity during embryogenesis. Nature 468:562–566
Dasgupta S, Wang G, Yu RK (2011) Sulfoglucuronosyl paragloboside promotes endothelial cell apoptosis in inflammation: elucidation of a novel glycosphingolipid-signaling pathway. J Neurochem 119:749–759
De Boer AG, Sutanto W (eds) (1997) Drug transport across the blood-brain barrier. Harwood, Amsterdam
DeBault LE, Cancilla PA (1980) Gamma-glutamyl transpeptidase in isolated brain endothelial cells: induction by glial cells in vitro. Science 207:653–655
Dehouck MP, Méresse S, Delorme P, Fruchart JC, Cecchelli R (1990) An easier, reproducible, and mass-production method to study the blood-brain barrier in vitro. J Neurochem 54:1798–1801
Deli MA, Abrahám CS, Kataoka Y, Niwa M (2005) Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology. Cell Mol Neurobiol 25:59–127
Dorovini-Zis K, Prameya R, Bowman PD (1991) Culture and characteristics of microvascular endothelial cells derived from human brain. Lab Invest 64:425–436
Duport S, Robert F, Muller D, Grau G, Parisi L, Stoppini L (1998) An in vitro blood-brain barrier model: cocultures between endothelial cells and organotypic brain slice cultures. Proc Natl Acad Sci U S A 95:1840–1845
Dutheil F, Jacob A, Dauchy S, Beaune P, Scherrmann JM, Declèves X, Loriot MA (2010) ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders. Expert Opin Drug Metab Toxicol 6:1161–1174
Ehrlich P (1885) Das Sauerstoffbeduerfnis des Organismus, In: Eine Farbenanalytische Studie. Hirschwald, Berlin
Förster C, Silwedel C, Golenhofen N, Burek M, Kietz S, Mankertz J, Drenckhahn D (2005) Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J Physiol 565:475–486
Franke H, Galla HJ, Beuckmann CT (1999) An improved low-permeability in vitro-model of the blood-brain barrier: transport studies on retinoids, sucrose, haloperidol, caffeine and mannitol. Brain Res 818:65–71
Franke H, Galla HJ, Beuckmann CT (2000) Primary cultures of brain microvessel endothelial cells: a valid and flexible model to study drug transport through the blood-brain barrier in vitro. Brain Res Brain Res Protoc 5:248–256
Fricker G (2002) Drug transport across the blood-brain barrier. In: Pelkonen O, Baumann A, Reichel A (eds) Pharmacokinetic challenges in drug discovery. Springer, Berlin
Gaillard PJ, de Boer AG (2000) Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur J Pharm Sci 12:95–102
Garberg P (1998) In vitro models of the blood-brain barrier. ATLA 28:821–847
Garberg P, Ball M, Borg N, Cecchelli R, Fenart L, Hurst RD, Lindmark T, Mabondzo A, Nilsson JE, Raub TJ, Stanimirovic D, Terasaki T, Oberg JO, Osterberg T (2005) In vitro models for the blood-brain barrier. Toxicol In Vitro 19:299–334
Ge S, Song L, Pachter JS (2005) Where is the blood-brain barrier … really? J Neurosci Res 79:421–427
Gibbs JE, Thomas SA (2002) The distribution of the anti-HIV drug, 2'3'-dideoxycytidine (ddC), across the blood-brain and blood-cerebrospinal fluid barriers and the influence of organic anion transport inhibitors. J Neurochem 80:392–404
Gil ES, Wu L, Xu L, Lowe TL (2012) β-Cyclodextrin-poly(β-amino ester) nanoparticles for sustained drug delivery across the blood-brain barrier. Biomacromolecules 13:3533–3541
Giri R, Selvaraj S, Miller CA, Hofman F, Yan SD, Stern D, Zlokovic BV, Kalra VK (2002) Effect of endothelial cell polarity on beta-amyloid-induced migration of monocytes across normal and AD endothelium. Am J Physiol Cell Physiol 283:C895–C904
Giurdanella G, Motta C, Muriana S, Arena V, Anfuso CD, Lupo G, Alberghina M (2011) Cytosolic and calcium-independent phospholipase A(2) mediate glioma-enhanced proangiogenic activity of brain endothelial cells. Microvasc Res 81:1–17
Grasset E, Pinto M, Dussaulx E, Zweibaum A, Desjeux JF (1984) Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters. Am J Physiol 247:C260–C267
Greenwood J, Pryce G, Devine L, Male DK, dos Santos WL, Calder VL, Adamson P (1996) SV40 large T immortalised cell lines of the rat blood-brain and blood-retinal barriers retain their phenotypic and immunological characteristics. J Neuroimmunol 71:51–63
Griep LM, Wolbers F, de Wagenaar B, ter Braak PM, Weksler BB, Romero IA, Couraud PO, Vermes I, van der Meer AD, van den Berg A (2013) BBB ON CHIP: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function. Biomed Microdevices 15:145–150
Hart MN, VanDyk LF, Moore SA, Shasby DM, Cancilla PA (1987) Differential opening of the brain endothelial barrier following neutralization of the endothelial luminal anionic charge in vitro. J Neuropathol Exp Neurol 46:141–153
Hartz AM, Bauer B, Soldner EL, Wolf A, Boy S, Backhaus R, Mihaljevic I, Bogdahn U, Klünemann HH, Schuierer G, Schlachetzki F (2012) Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy. Stroke 43:514–523
Hatherell K, Couraud PO, Romero IA, Weksler B, Pilkington GJ (2011) Development of a three-dimensional, all-human in vitro model of the blood-brain barrier using mono-, co-, and tri-cultivation Transwell models. J Neurosci Methods 199:223–229
Hellinger E, Veszelka S, Tóth AE, Walter F, Kittel A, Bakk ML, Tihanyi K, Háda V, Nakagawa S, Duy TD, Niwa M, Deli MA, Vastag M (2012) Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models. Eur J Pharm Biopharm 82:340–351
Helms HC, Waagepetersen HS, Nielsen CU, Brodin B (2010) Paracellular tightness and claudin-5 expression is increased in the BCEC/astrocyte blood-brain barrier model by increasing media buffer capacity during growth. AAPS J 12:759–770
Helms HC, Madelung R, Waagepetersen HS, Nielsen CU, Brodin B (2012) In vitro evidence for the brain glutamate efflux hypothesis: brain endothelial cells cocultured with astrocytes display a polarized brain-to-blood transport of glutamate. Glia 60:882–893
Hoheisel D, Nitz T, Franke H, Wegener J, Hakvoort A, Tilling T, Galla HJ (1998) Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. Biochem Biophys Res Commun 247:312–315
Hoshi Y, Uchida Y, Tachikawa M, Inoue T, Ohtsuki S, Terasaki T (2013) Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset. J Pharm Sci 102:3343–3355
Hosoya KI, Takashima T, Tetsuka K, Nagura T, Ohtsuki S, Takanaga H, Ueda M, Yanai N, Obinata M, Terasaki T (2000) mRNA expression and transport characterization of conditionally immortalized rat brain capillary endothelial cell lines; a new in vitro BBB model for drug targeting. J Drug Target 8:357–370
Hosoya K, Tomi M, Ohtsuki S, Takanaga H, Ueda M, Yanai N, Obinata M, Terasaki T (2001) Conditionally immortalized retinal capillary endothelial cell lines (TR-iBRB) expressing differentiated endothelial cell functions derived from a transgenic rat. Exp Eye Res 72:163–172
Huber O, Brunner A, Maier P, Kaufmann R, Couraud PO, Cremer C, Fricker G (2012) Localization microscopy (SPDM) reveals clustered formations of P-glycoprotein in a human blood-brain barrier model. PLoS One 7(9):e44776. doi:10.1371/journal.pone.0044776
Hurst RD, Fritz IB (1996) Properties of an immortalised vascular endothelial/glioma cell co-culture model of the blood-brain barrier. J Cell Physiol 167:81–88
Ito K, Uchida Y, Ohtsuki S, Aizawa S, Kawakami H, Katsukura Y, Kamiie J, Terasaki T (2011a) Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys. J Pharm Sci 100:3939–3950
Ito S, Ohtsuki S, Katsukura Y, Funaki M, Koitabashi Y, Sugino A, Murata S, Terasaki T (2011b) Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-C-mediated brain-to-blood efflux transport at the blood-brain barrier. J Cereb Blood Flow Metab 31:457–466
Ito S, Ohtsuki S, Nezu Y, Koitabashi Y, Murata S, Terasaki T (2011c) 1α,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide(1-40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS 8:20. doi:10.1186/2045-8118-8-20
Janigro D, Leaman SM, Stanness KA (1999) Dynamic modeling of the blood-brain barrier: a novel tool for studies of drug delivery to the brain. Pharm Sci Technolo Today 2:7–12
Janson C, Romanova L, Hansen E, Hubel A, Lam C (2011) Immortalization and functional characterization of rat arachnoid cell lines. Neuroscience 177:23–34
Joó F (1992) The cerebral microvessels in culture, an update. J Neurochem 58:1–17
Joó F, Karnushina I (1973) A procedure for the isolation of capillaries from rat brain. Cytobios 8:41–48
Kamiie J, Ohtsuki S, Iwase R, Ohmine K, Katsukura Y, Yanai K, Sekine Y, Uchida Y, Ito S, Terasaki T (2008) Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm Res 25:1469–1483
Karlstedt K, Jin C, Panula P (2013) Expression of histamine receptor Hrh3 and Hrh4 in rat brain endothelial cells. Br J Pharmacol 170:58–66
Kasa P, Pakaski M, Joó F, Lajtha A (1991) Endothelial cells from human fetal brain microvessels may be cholinoceptive, but do not synthesize acetylcholine. J Neurochem 56:2143–2146
Kido Y, Tamai I, Okamoto M, Suzuki F, Tsuji A (2000) Functional clarification of MCT1-mediated transport of monocarboxylic acids at the blood-brain barrier using in vitro cultured cells and in vivo BUI studies. Pharm Res 17:555–562
Kovács R, Papageorgiou I, Heinemann U (2011) Slice cultures as a model to study neurovascular coupling and blood brain barrier in vitro. Cardiovasc Psychiatry Neurol 2011:646958. doi:10.1155/2011/646958
Krämer SD, Abbott NJ, Begley DJ (2001) Biological models to study blood-brain barrier permeation. In: Testa B, van de Waterbeemd H, Folkers G, Guy R (eds) Pharmacokinetic optimization in drug research: biological, physicochemical and computational strategies. Wiley-VCH, Weinheim
Lam CH, Hansen EA, Hubel A (2011) Arachnoid cells on culture plates and collagen scaffolds: phenotype and transport properties. Tissue Eng Part A 17:1759–1766
Lam CH, Hansen EA, Janson C, Bryan A, Hubel A (2012) The characterization of arachnoid cell transport II: paracellular transport and blood-cerebrospinal fluid barrier formation. Neuroscience 222:228–238
Larochelle C, Cayrol R, Kebir H, Alvarez JI, Lécuyer MA, Ifergan I, Viel É, Bourbonnière L, Beauseigle D, Terouz S, Hachehouche L, Gendron S, Poirier J, Jobin C, Duquette P, Flanagan K, Yednock T, Arbour N, Prat A (2012) Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system. Brain 135:2906–2924
Lee NY, Choi HO, Kang YS (2012) The acetylcholinesterase inhibitors competitively inhibited an acetyl L-carnitine transport through the blood-brain barrier. Neurochem Res 37:1499–1507
Li YJ, Boado RJ, Pardridge WM (2001) Blood-brain barrier genomics. J Cereb Blood Flow Metab 21:61–68
Li JY, Boado RJ, Pardridge WM (2002) Rat blood-brain barrier genomics. II. J Cereb Blood Flow Metab 22:1319–1326
Lippmann ES, Azarin SM, Kay JE, Nessler RA, Wilson HK, Al-Ahmad A, Palecek SP, Shusta EV (2012) Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells. Nat Biotechnol 30:783–791
Lippmann ES, Al-Ahmad A, Palecek SP, Shusta EV (2013) Modeling the blood-brain barrier using stem cell sources. Fluids Barriers CNS 10(1):2. doi:10.1186/2045-8118-10-2
Liu KK, Dorovini-Zis K (2012) Differential regulation of CD4+ T cell adhesion to cerebral microvascular endothelium by the chemokines CCL2 and CCL3. Int J Mol Sci 13:16119–16140
Lohmann C, Hüwel S, Galla HJ (2002) Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays. J Drug Target 10:263–276
Lundquist S, Renftel M, Brillault J, Fenart L, Cecchelli R, Dehouck MP (2002) Prediction of drug transport through the blood-brain barrier in vivo: a comparison between two in vitro cell models. Pharm Res 19:976–981
Macdonald JA, Murugesan N, Pachter JS (2010) Endothelial cell heterogeneity of blood-brain barrier gene expression along the cerebral microvasculature. J Neurosci Res 88:1457–1474
Miller DS (2010) Regulation of P-glycoprotein and other ABC drug transporters at the blood-brain barrier. Trends Pharmacol Sci 31:246–254
Miller DW, Audus KL, Borchardt RT (1992) Application of cultured endothelial cells of the brain microvasculature in the study of the blood-brain barrier. J Tiss Cult Meth 14:217–224
Miller DS, Nobmann SN, Gutmann H, Toeroek M, Drewe J, Fricker G (2000) Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol Pharm 58:1357–1367
Monnot AD, Zheng W (2013) Culture of choroid plexus epithelial cells and in vitro model of blood-CSF barrier. Methods Mol Biol 945:13–29
Mukhtar M, Pomerantz RJ (2000) Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection. J Hum Virol 3:324–334
Muruganandam A, Herx LM, Monette R, Durkin JP, Stanimirovic DB (1997) Development of immortalized cerebromicrovascular endothelial cell line as an in vitro model of the human blood-brain barrier. FASEB J 11:1187–1197
Naik P, Cucullo L (2012) In vitro blood-brain barrier models: current and perspective technologies. J Pharm Sci 101:1337–1354
Nakagawa S, Deli MA, Kawaguchi H, Shimizudani T, Shimono T, Kittel A, Tanaka K, Niwa M (2009) A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes. Neurochem Int 54:253–263
Neuhaus W, Germann B, Plattner VE, Gabor F, Wirth M, Noe CR (2009) Alteration of the glycocalyx of two blood-brain barrier mimicking cell lines is inducible by glioma conditioned media. Brain Res 1279:82–89
Ohtsuki S, Uchida Y, Kubo Y, Terasaki T (2011) Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects. J Pharm Sci 100:3547–3559
Okura T, Ito R, Ishiguro N, Tamai I, Deguchi Y (2007) Blood-brain barrier transport of pramipexole, a dopamine D2 agonist. Life Sci 80:1564–1571
Panula P, Joó F, Rechardt L (1978) Evidence for the presence of viable endothelial cells in cultures derived from dissociated rat brain. Experientia 34:95–97
Pardridge WM (1998) Isolated brain capillaries: an in vitro model of blood-brain barrier research. In: Pardridge WM (ed) Introduction to the blood-brain barrier: methodology, biology and pathology. Cambridge University Press, Cambridge UK
Patabendige A, Skinner RA, Abbott NJ (2013a) Establishment of a simplified in vitro porcine blood-brain barrier model with high transendothelial electrical resistance. Brain Res 1521:1–15
Patabendige A, Skinner RA, Morgan L, Abbott NJ (2013b) A detailed method for preparation of a functional and flexible blood-brain barrier model using porcine brain endothelial cells. Brain Res 1521:16–30
Paul D, Cowan AE, Ge S, Pachter JS (2013) Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels. Microvasc Res 86:1–10
Perrière N, Demeuse P, Garcia E, Regina A, Debray M, Andreux JP, Couvreur P, Scherrmann JM, Temsamani J, Couraud PO, Deli MA, Roux F (2005) Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem 93:279–289
Pottiez G, Duban-Deweer S, Deracinois B, Gosselet F, Camoin L, Hachani J, Couraud PO, Cecchelli R, Dehouck MP, Fenart L, Karamanos Y, Flahaut C (2011) A differential proteomic approach identifies structural and functional components that contribute to the differentiation of brain capillary endothelial cells. J Proteomics 75:628–641
Prabhakarpandian B, Shen MC, Nichols JB, Mills IR, Sidoryk-Wegrzynowicz M, Aschner M, Pant K (2013) SyM-BBB: a microfluidic blood brain barrier model. Lab Chip 13:1093–1101
Preston JE, Segal MB, Walley GJ, Zlokovic BV (1989) Neutral amino acid uptake by the isolated perfused sheep choroid plexus. J Physiol 408:31–43
Priya Eddy E, Maleef BE, Hart TK, Smith PL (1997) In vitro models to predict blood-brain barrier permeability. Adv Drug Deliv Rev 23:185–198
Qiao R, Jia Q, Hüwel S, Xia R, Liu T, Gao F, Galla HJ, Gao M (2012) Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier. ACS Nano 6:3304–3310
Raub TJ, Kuentzel SL, Sawada GA (1992) Permeability of bovine brain microvessel endothelial cells in vitro: barrier tightening by a factor released from astroglioma cells. Exp Cell Res 199:330–340
Redzic ZB (2013) Studies on the human choroid plexus in vitro. Fluids Barriers CNS 10(1):10. doi:10.1186/2045-8118-10-10
Régina A, Romero IA, Greenwood J, Adamson P, Bourre JM, Couraud PO, Roux F (1999) Dexamethasone regulation of P-glycoprotein activity in an immortalized rat brain endothelial cell line, GPNT. J Neurochem 73:1954–1963
Reichel A, Begley DJ, Abbott NJ (2003) An overview of in vitro techniques for blood-brain barrier studies. Methods Mol Med 89:307–324
Ribeiro MM, Castanho MA, Serrano I (2010) In vitro blood-brain barrier models–latest advances and therapeutic applications in a chronological perspective. Mini Rev Med Chem 10:262–270
Riganti C, Salaroglio IC, Pinzòn-Daza ML, Caldera V, Campia I, Kopecka J, Mellai M, Annovazzi L, Couraud PO, Bosia A, Ghigo D, Schiffer D (2013) Temozolomide down-regulates P-glycoprotein in human blood-brain barrier cells by disrupting Wnt3 signaling. Cell Mol Life Sci
Roux F, Couraud PO (2005) Rat brain endothelial cell lines for the study of blood-brain barrier permeability and transport functions. Cell Mol Neurobiol 25:41–58
Roux F, Durieu-Trautmann O, Chaverot N, Claire M, Mailly P, Bourre JM, Strosberg AD, Couraud PO (1994) Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol 159:101–113
Rubin LL, Hall DE, Porter S, Barbu K, Cannon C, Horner HC, Janatpour M, Liaw CW, Manning K, Morales J, Tanner LI, Tomaselli KJ, Bard F (1991) A cell culture model of the blood-brain barrier. J Cell Biol 115:1725–1735
Rutten MJ, Hoover RL, Karnovsky MJ (1987) Electrical resistance and macromolecular permeability of brain endothelial monolayer cultures. Brain Res 425:301–310
Saubaméa B, Cochois-Guégan V, Cisternino S, Scherrmann JM (2012) Heterogeneity in the rat brain vasculature revealed by quantitative confocal analysis of endothelial barrier antigen and P-glycoprotein expression. J Cereb Blood Flow Metab 32:81–92
Schroten M, Hanisch FG, Quednau N, Stump C, Riebe R, Lenk M, Wolburg H, Tenenbaum T, Schwerk C (2012) A novel porcine in vitro model of the blood-cerebrospinal fluid barrier with strong barrier function. PLoS One 7(6):e39835. doi:10.1371/journal.pone.0039835
Shah KK, Yang L, Abbruscato TJ (2012) In vitro models of the blood-brain barrier. Methods Mol Biol 814:431–449
Shawahna R, Uchida Y, Declèves X, Ohtsuki S, Yousif S, Dauchy S, Jacob A, Chassoux F, Daumas-Duport C, Couraud PO, Terasaki T, Scherrmann JM (2011) Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels. Mol Pharm 8:1332–1341
Shawahna R, Decleves X, Scherrmann JM (2013) Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes. Curr Drug Metab 14:120–136
Shirai A, Naito M, Tatsuta T, Dong J, Hanaoka K, Mikami K, Oh-hara T, Tsuruo T (1994) Transport of cyclosporin A across the brain capillary endothelial cell monolayer by P-glycoprotein. Biochim Biophys Acta 1222:400–404
Siakotos AN, Rouser G (1969) Isolation of highly purified human and bovine brain endothelial cells and nuclei and their phospholipid composition. Lipids 4:234–239
Skinner RA, Gibson RM, Rothwell NJ, Pinteaux E, Penny JI (2009) Transport of interleukin-1 across cerebromicrovascular endothelial cells. Br J Pharmacol 156:1115–1123
Stanness KA, Guatteo E, Janigro D (1996) A dynamic model of the blood-brain barrier “in vitro”. Neurotoxicology 17:481–496
Stanness KA, Westrum LE, Fornaciari E, Mascagni P, Nelson JA, Stenglein SG, Myers T, Janigro D (1997) Morphological and functional characterization of an in vitro blood-brain barrier model. Brain Res 771:329–342
Steiner O, Coisne C, Engelhardt B, Lyck R (2011) Comparison of immortalized bEnd5 and primary mouse brain microvascular endothelial cells as in vitro blood-brain barrier models for the study of T cell extravasation. J Cereb Blood Flow Metab 31:315–327
Strazielle N, Ghersi-Egea JF (1999) Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics. J Neurosci 19:6275–6289
Strazielle N, Ghersi-Egea JF (2013) Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm 10:1473–1491
Summerfield SG, Read K, Begley DJ, Obradovic T, Hidalgo IJ, Coggon S, Lewis AV, Porter RA, Jeffrey P (2007) Central nervous system drug disposition: the relationship between in situ brain permeability and brain free fraction. J Pharmacol Exp Ther 322:205–313
Tega Y, Akanuma S, Kubo Y, Terasaki T, Hosoya K (2013) Blood-to-brain influx transport of nicotine at the rat blood-brain barrier: involvement of a pyrilamine-sensitive organic cation transport process. Neurochem Int 62:173–181
Terasaki T, Hosoya K (2001) Conditionally immortalized cell lines as a new in vitro model for the study of barrier functions. Biol Pharm Bull 24:111–118
Terasaki T, Ohtsuki S, Hori S, Takanaga H, Nakashima E, Hosoya K (2003) New approaches to in vitro models of blood-brain barrier drug transport. Drug Discov Today 8:944–954
Thanabalasundaram G, Schneidewind J, Pieper C, Galla HJ (2011) The impact of pericytes on the blood-brain barrier integrity depends critically on the pericyte differentiation stage. Int J Biochem Cell Biol 43:1284–1293
Thornton P, McColl BW, Cooper L, Rothwell NJ, Allan SM (2010) Interleukin-1 drives cerebrovascular inflammation via MAP kinase-independent pathways. Curr Neurovasc Res 7:330–340
Uchida Y, Ohtsuki S, Kamiie J, Terasaki T (2011a) Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice. J Pharmacol Exp Ther 339:579–588
Uchida Y, Ohtsuki S, Katsukura Y, Ikeda C, Suzuki T, Kamiie J, Terasaki T (2011b) Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors. J Neurochem 117:333–345
Uchida Y, Tachikawa M, Obuchi W, Hoshi Y, Tomioka Y, Ohtsuki S, Terasaki T (2013) A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters, receptors, claudin-5, and marker proteins at the blood-brain barrier in ddY, FVB, and C57BL/6J mice. Fluids Barriers CNS 10(1):21. doi:10.1186/2045-8118-10-21
Usui T, Kubo Y, Akanuma SI, Hosoya KI (2013) β-Alanine and l-histidine transport across the inner blood-retinal barrier: potential involvement in l-carnosine supply. Exp Eye Res 113:135–142
Vandenhaute E, Dehouck L, Boucau MC, Sevin E, Uzbekov R, Tardivel M, Gosselet F, Fenart L, Cecchelli R, Dehouck MP (2011) Modelling the neurovascular unit and the blood-brain barrier with the unique function of pericytes. Curr Neurovasc Res 8:258–269
Vandenhaute E, Sevin E, Hallier-Vanuxeem D, Dehouck MP, Cecchelli R (2012) Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery. Drug Discov Today 17:285–290
Vilas-Boas V, Silva R, Nunes C, Reis S, Ferreira L, Vieira C, Carvalho F, Bastos MD, Remião F (2013) Mechanisms of P-gp inhibition and effects on membrane fluidity of a new rifampicin derivative, 1,8-dibenzoyl-rifampicin. Toxicol Lett 220:259–266
Wagner EF, Risau W (1994) Oncogenes in the study of endothelial cell growth and differentiation. Semin Cancer Biol 5:137–145
Wallace BK, Foroutan S, O’Donnell ME (2011) Ischemia-induced stimulation of Na-K-Cl cotransport in cerebral microvascular endothelial cells involves AMP kinase. Am J Physiol Cell Physiol 301:C316–C326
Wang Q, Luo W, Zhang W, Liu M, Song H, Chen J (2011) Involvement of DMT1 + IRE in the transport of lead in an in vitro BBB model. Toxicol In Vitro 25:991–998
Wang S, Qaisar U, Yin X, Grammas P (2012) Gene expression profiling in Alzheimer’s disease brain microvessels. J Alzheimers Dis 31:193–205
Watanabe T, Dohgu S, Takata F, Nishioku T, Nakashima A, Futagami K, Yamauchi A, Kataoka Y (2013) Paracellular barrier and tight junction protein expression in the immortalized brain endothelial cell lines bEND.3, bEND.5 and mouse brain endothelial cell 4. Biol Pharm Bull 36:492–495
Watson PM, Paterson JC, Thom G, Ginman U, Lundquist S, Webster CI (2013) Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier. BMC Neurosci 14(1):59
Wegener J, Sieber M, Galla HJ (1996) Impedance analysis of epithelial and endothelial cell monolayers cultured on gold surfaces. J Biochem Biophys Methods 32:151–170
Wegener J, Hakvoort A, Galla HJ (2000) Barrier function of porcine choroid plexus epithelial cells is modulated by cAMP-dependent pathways in vitro. Brain Res 853:115–124
Weksler BB, Subileau EA, Perrière N, Charneau P, Holloway K, Leveque M, Tricoire-Leignel H, Nicotra A, Bourdoulous S, Turowski P, Male DK, Roux F, Greenwood J, Romero IA, Couraud PO (2005) Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J 19:1872–1874
Weksler B, Romero IA, Couraud PO (2013) The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10(1):16. doi:10.1186/2045-8118-10-16
Williams RL, Courtneidge SA, Wagner EF (1988) Embryonic lethalities and endothelial tumors in chimeric mice expressing polyoma virus middle T oncogene. Cell 52:121–131
Williams RL, Risau W, Zerwes HG, Drexler H, Aguzzi A, Wagner EF (1989) Endothelioma cells expressing the polyoma middle T oncogene induce hemangiomas by host cell recruitment. Cell 57:1053–1063
Wilson G (1990) Cell culture techniques for the study of drug transport. Eur J Drug Metab Pharmacokinet 15:159–163
Yasuda K, Cline C, Vogel P, Onciu M, Fatima S, Sorrentino BP, Thirumaran RK, Ekins S, Urade Y, Fujimori K, Schuetz EG (2013) Drug transporters on arachnoid barrier cells contribute to the blood-cerebrospinal fluid barrier. Drug Metab Dispos 41:923–931
Youdim KA, Avdeef A, Abbott NJ (2003) In vitro trans-monolayer permeability calculations: often forgotten assumptions. Drug Discov Today 8:997–1003
Zhang Y, Li CS, Ye Y, Johnson K, Poe J, Johnson S, Bobrowski W, Garrido R, Madhu C (2006) Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability. Drug Metab Dispos 34:1935–1943
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 American Association of Pharmaceutical Scientists
About this chapter
Cite this chapter
Abbott, N.J., Dolman, D.E.M., Yusof, S.R., Reichel, A. (2014). In Vitro Models of CNS Barriers. In: Hammarlund-Udenaes, M., de Lange, E., Thorne, R. (eds) Drug Delivery to the Brain. AAPS Advances in the Pharmaceutical Sciences Series, vol 10. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-9105-7_6
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9105-7_6
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-9104-0
Online ISBN: 978-1-4614-9105-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)